You've got a solid product or service. You know it works. But getting in front of the right people at pharmaceutical companies, biotech firms, and clinical organizations feels impossible.
Your emails get ignored. When you do get responses, they're usually "send us your info" followed by radio silence. Or worse - you're getting replies from people with zero decision-making power.
The problem isn't your product. It's that you're approaching B2B therapeutics cold email the same way everyone else is - generically, at scale, without actually understanding the buyer.
Let's fix that.
Therapeutics is a weird vertical for cold outreach. The sales cycle is long. The decision-makers are scattered across different departments. Compliance and regulatory concerns mean people are cautious about who they engage with. And there's a ton of noise - everyone's trying to sell something to pharma.
Most cold emails fail here because they treat therapeutics like SaaS. They use generic subject lines, try to cram value into three paragraphs, and hope volume makes up for lack of targeting.
That approach gets you maybe a 1-2% response rate - and most of those responses are from the wrong people.
What actually works is different. It requires understanding your prospect's actual world - what regulatory bodies they answer to, what their compliance team cares about, what KPIs their leadership is measuring, what problems are keeping them up at night.
This is where most people fail, and it's also where you gain your edge.
Don't email everyone at a pharma company. Don't even email "all the VPs of Operations." Get specific.
Are you selling a manufacturing solution? Then you need the person who owns supply chain at that specific company - and you need to know if they're dealing with capacity issues right now. Are you offering a clinical trial management tool? Find the Clinical Operations Director who recently got promoted or changed roles - they're more likely to want to improve processes than someone settled into their position.
Use LinkedIn to understand their actual background. Read their recent activity. If they posted about a challenge or initiative, you now have leverage.
The targeting part matters more than the email itself. A mediocre email to the right person beats a brilliant email to the wrong person every time.
Once you've identified the right person, your email needs to show that you actually know something about them and their company - not just guesses.
Reference something specific. Not "I noticed you work in manufacturing" - that's lazy. Reference an actual decision they've made, a challenge their company recently faced, or a regulatory change that just hit their industry.
Then connect it directly to what you do.
Here's the structure that works:
The whole email should be 5-6 sentences. Not a paragraph dump. Therapeutics professionals are busy. Respect their time.
Cold email in B2B therapeutics isn't magic. You're not going to get a 20% response rate. You might get 3-5% from the right list with the right targeting.
But those responses matter because they're from decision-makers who are actually interested.
Also, the sales cycle is long. Someone might not be ready to move forward when you email them, but they'll remember you when their current vendor fails or when their budget situation changes. That's why follow-up matters - send 3-4 thoughtful follow-ups over 2-3 weeks. Each one should add new information or show that you've done more research, not just "just checking in."
What works for one company might not work for another. A subject line that crushes it with Clinical Operations VPs might flop with Supply Chain Directors.
Keep track of what gets opens, what gets responses, and from who. Then adjust. Maybe your messaging about regulatory compliance resonates but your pitch about cost savings doesn't. Double down on what works.
Use a spreadsheet or CRM to track:
This data is gold. It tells you what's actually working in your market.
All of this works. But it requires research upfront, thoughtful copy for each prospect (or at least each segment), consistent follow-up, and the ability to handle replies professionally and quickly.
If you're doing this yourself while running your business, that's a lot of overhead.
This is exactly the kind of work that compounds - the more you do it, the better your data gets, the better your messaging becomes, the higher your response rates climb. But getting to that point takes months if you're doing it alone.
That's why some service businesses and agencies work with partners like BEC Growth - they handle the entire infrastructure. Lead research, list building, copy tailored to your offer, sending campaigns, handling and qualifying replies, and managing follow-ups. You just focus on closing.
If you're serious about filling your pipeline with actual B2B therapeutics prospects, that's worth considering. The math usually works out - even if you're not doing it yourself, having someone own this process means you get consistent inbound from qualified buyers.
Start with the targeting. Everything else flows from that.
Ready to Sign Clients On-Demand?
BEC Growth builds and manages your entire cold email system from infrastructure to reply handling.
Book a Call →